VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company at the forefront […]
Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole […]